Soonchunhyang University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Asan Korea, Republic of (1978)

Organization Overview

First Clinical Trial
2006
NCT00504192
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Bucheon Hospital, Soonchunhyang University | DEPARTMENT OF PSYCHIATRY SOONCHUNHYANG UNIVERSITY BUCHEOMN HOSPITAL | Pediatric Allergy & Respiratory Center, Department of Pediatrics, Soonchunhyang University Hospital | Pyun BokYang | Soonchunhayng Universtiy Seoul Hospital | Soon Chun Hyang Hospital, Seoul, Korea | Soonchunhyang University Buchen Hospital | Soon Chun Hyang University Bucheon Hospital of Korea | Soonchunhyang university Cheonan Hospital | Soonchunhyang University Cheonan Hospital | Soonchunhyang University College of Medicine | Soonchunhyang University Hospital | Soon Chun Hyang University Hospital | Soonchunhyang University Hospital, Choenan, Chungchoengnam-do, Korea, Republic of | Soon Chun Hyang University Hospital, Department of Neurology | Soonchunhyang University Hospital Seoul | Soon Chun Hyang University Hospital , Seoul, Korea | Soonchunhyang University Hospital, Seoul, Korea, Republic of | Soon Chun Hyang Univ. Hospital | Soonchunhyang U Puchun Hospital

Active Ingredients

Drugs in Phase 4 Trials (32)

5,7-dihydroxy-3',4',6-trimethoxyflavone (1 trial)

acetylsalicylic acid (aspirin) (3 trials)

adefovir dipivoxil (hepsera) (1 trial)

aminosyn ii (1 trial)

celecoxib (celebrex) (2 trials)

cilostazol (pletal) (1 trial)

ciprofloxacin (cipro) (2 trials)

clopidogrel (plavix) (1 trial)

daclatasvir (daklinza) (2 trials)

entecavir (baraclude) (2 trials)

imatinib (gleevec) (1 trial)

interferon alpha-2b (Intron-A) (2 trials)

lamivudine (epivir) (2 trials)

lansoprazole (prevacid) (1 trial)

lidocaine (xylocaine) (2 trials)

melatonin (1 trial)

motilitone (2 trials)

multi-valent pneumococcal conjugate vaccine (1 trial)

norfloxacin (noroxin) (1 trial)

pantoline (2 trials)

prilocaine (citanest) (1 trial)

propofol (diprivan) (2 trials)

rebamipide (3 trials)

ribavirin (virazole) (1 trial)

sargramostim (leukine) (1 trial)

solifenacin (vesicare) (1 trial)

sunvepra (2 trials)

tamsulosin (flomax) (1 trial)

telbivudine (tyzeka) (1 trial)

tenofovir (viread) (3 trials)

tolvaptan (samsca) (1 trial)

ziprasidone (geodon) (1 trial)

Drugs in Phase 3 Trials (23)

allogeneic adipose derived mesenchymal stem cell (1 trial)

amlodipine (norvasc) (2 trials)

besifovir (1 trial)

capecitabine (xeloda) (2 trials)

carvedilol (coreg) (1 trial)

fimasartan (kanarb) (2 trials)

fluarix (1 trial)

furestem (1 trial)

gimeracil (2 trials)

hcp1102 (1 trial)

hgp0711 (1 trial)

hydrochlorothiazide (esidrix) (1 trial)

inactivated influenza vaccine (2 trials)

levodropropizine (1 trial)

olmesartan (benicar) (1 trial)

oteracil (2 trials)

oxaliplatin (eloxatin) (6 trials)

pranlukast (1 trial)

recoflavone (1 trial)

s-1 (2 trials)

tegafur (2 trials)

theostene (1 trial)

valsartan (diovan) (1 trial)

Drugs in Phase 2 Trials (16)

busulfan (myleran) (2 trials)

cyclophosphamide (cytoxan) (1 trial)

docetaxel (taxotere) (1 trial)

erlotinib (tarceva) (1 trial)

etoposide (vepesid) (2 trials)

fluorouracil (efudex) (1 trial)

gemcitabine (gemzar) (2 trials)

idarubicin (idamycin) (1 trial)

irinotecan (Camptosar) (1 trial)

leucovorin (1 trial)

melphalan (alkeran) (2 trials)

neu2000kwl (1 trial)

rituximab (rituxan) (1 trial)

sirolimus (rapamune) (1 trial)

sp-8203 (1 trial)

tacrolimus (prograf) (1 trial)

Drugs in Other Trials (12)

chlorhexidine (hibitane) (1 trial)

clarithromycin (biaxin) (1 trial)

dexlansoprazole (dexilant) (1 trial)

fentanyl (Innovar) (1 trial)

hyaluronic acid (1 trial)

ins365 (1 trial)

melilotus officinalis (1 trial)

montelukast (singulair) (1 trial)

probiotic (1 trial)

ropivacaine (naropin) (1 trial)

triamcinolone (kenalog) (1 trial)

yinhsing (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Ascites (Phase 4)

Biliary Tract Neoplasms (Phase 2)

Bronchitis (Phase 3)

Bursitis (Phase 4)

Carcinoma (Phase 2)

Carcinoma, Large Cell (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Cerebral Infarction (Phase 2)

Colorectal Neoplasms (Phase 3)

Coronary Artery Disease (Phase 4)

Crohn Disease (Phase 4)

Dyspepsia (Phase 4)

Dyssomnias (Phase 4)

Esophagitis (Phase 4)

Esophagitis, Peptic (Phase 4)

Essential Hypertension (Phase 3)

Gastritis (Phase 4)

Gastroesophageal Reflux (Phase 4)

Graft vs Host Disease (Phase 2)

Heart Arrest (Phase 2)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hypertension (Phase 3)

Hyponatremia (Phase 4)

Influenza, Human (Phase 3)

Ischemia (Phase 2)

Kidney Failure, Chronic (Phase 4)

Leukemia (Phase 4)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 4)

Leukemia, Myeloid (Phase 4)

Leukemia, Myeloid, Accelerated Phase (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Leukemia, Myeloid, Chronic-Phase (Phase 2)

Liver Diseases (Phase 4)

Lymphoma (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Myocardial Reperfusion Injury (Phase 4)

Neutropenia (Phase 4)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 3)

Out-of-Hospital Cardiac Arrest (Phase 2)

Pancreatic Neoplasms (Phase 2)

Parasomnias (Phase 4)

Parkinson Disease (Phase 4)

Peritonitis (Phase 4)

Psychotic Disorders (Phase 4)

Renal Insufficiency (Phase 4)

Reperfusion Injury (Phase 4)

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 3)

Rhinitis, Allergic, Perennial (Phase 3)

Schizophrenia (Phase 4)

Sleep Wake Disorders (Phase 4)

Stomach Neoplasms (Phase 2)

Stroke (Phase 2)

Urinary Bladder, Overactive (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 63
  • # of Trial APIs: 83